|
|
||||||||||||||||||
Article Navigation
|
Lighting the Way to Fight Breast Cancerby: ARA (ARA) - Being a woman and getting older are the main risk factors for breast cancer. This year, more than 200,000 women in the United States will be diagnosed with breast cancer, and nearly 40,000 women will lose their lives to the disease. Although you cannot control your sex or age, there are other factors related to personal, everyday choices that can be controlled, and may help reduce your risk for breast cancer. Control Your Risk Factors The risk factors you can control that may decrease your risk of getting breast cancer include: not having more than one drink of alcohol per day; not being overweight after menopause nor gaining weight as an adult; not taking birth control pills for five years or longer; and having children, especially before the age of 30. Eat Right and Exercise For overall wellness and also to possibly decrease the risk for developing breast cancer, it is recommended that women consume a well-balanced diet rich in fruits and vegetables. Physical activity may protect you from breast cancer if you are pre-menopausal or are a younger postmenopausal woman. Exercise reduces estrogen levels, fights obesity, lowers insulin levels and boosts the immune system. Support the Fight Against Breast Cancer Where You See the Pink Ribbon Another important piece you can control is your support of organizations that are leading the fight against breast cancer, often with the help of retail partners. For seven years, Pier 1 Imports has sold the “Komen Candle” with 25 percent of the purchase price (less tax) benefiting the Susan G. Komen Breast Cancer Foundation to support innovative breast cancer research and community outreach programs. Last year, sales of the candle raised more than $176,000 for the Komen Foundation. “A key to our success at the Komen Foundation is that we collaborate with a variety of companies and organizations to provide creative ways for people to make a difference in the fight against breast cancer,” said Cindy Schneible, vice president of cause-related marketing and sponsorship for the Komen Foundation. “ Pier 1’s ‘Komen Candle’ enables the Komen Foundation to reach more women with the life-saving message of early detection and to raise funds for breast cancer research, education, screening and treatment programs.” Starting late August, the signature Floral Blush-scented candle will be sold in Pier 1 stores nationwide. For more information about breast health or breast cancer, call the Komen Foundation’s National Toll-Free Breast Care Helpline at (800) I’M AWARE (462-9273) or visit the Web site at www.komen.org. Courtesy of ARA Content Latest Cancer News:Cancer drug dramatically shrinks prostate tumors, study finds (Los Angeles Times) The survival rate more than doubles among most of the men with aggressive cancers. A second, wider test shows similar results. 'Spectacularly effective,' a researcher says. An experimental cancer drug shrank prostate tumors dramatically and more than doubled survival in 70% to 80% of patients with aggressive cancers, British researchers reported Tuesday. Symphony director's kidney cancer removed (CNN.com) BOSTON, Massachusetts (AP) -- A growth on a kidney removed from conductor James Levine was malignant, but doctors say the cancer was caught early and no further treatment is needed, the Boston Symphony Orchestra said in a statement Tuesday. More Cancer Lymph Nodes Analyzed at Specialty Centers (HealthDay via Yahoo! News) TUESDAY, July 22 (HealthDay News) -- Patients with stomach or pancreatic cancer may have more lymph nodes examined for the spread of cancer if they're treated at designated comprehensive cancer centers or at hospitals that do a high number of cancer surgeries, says a U.S. study. Advance vs. prostate cancer (Denver Post) An experimental cancer drug shrank prostate tumors dramatically and more than doubled survival in 70 percent to 80 percent of patients with aggressive cancers, British researchers reported Tuesday. Drug combats untreatable prostate cancer (UPI) LONDON, July 22 (UPI) -- The Phase 1 clinical trial of the drug abiraterone revealed significant tumor shrinkage in men with advanced prostate cancer, researchers in Britain said. Cancer society bus coming to Naperville, Schaumburg (Daily Herald) The American Cancer Society Cancer Action Network is on tour, encouraging people to get involved in the political end of the fight against a disease that ranks among the top killers in the country. Prostate cancer drug hailed as breakthrough (The New Zealand Herald) A new prostate cancer drug showing stunning results in Britain could successfully treat hundreds of New Zealand men. Breast cancer survivor to speak at conference (The Press-Enterprise) RIVERSIDE - Nikia Hammonds-Blakely, who survived breast cancer at age 16, will speak about her struggle at the fourth annual Healthy Heritage Wellness Conference on Saturday at Cal Baptist University. Rise in breast cancer among Native women may be leveling (Anchorage Daily News) A mysterious 30-year-long increase in breast cancer rates among Alaska Native women may finally be leveling off -- after tripling between 1969 and 1998. A relaxing way to help fight breast cancer (Daily Herald) When Amy Tabisz was 18 years old her mother died of breast cancer. Celebs That Cancer Can't Hold Back - ABC News
|
|||||||||||||||||